Cite Filings / AVLN
Feed Companies Filings Check
Sign in

CIK 0001540171 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Avalyn Pharma Inc.

Sign in to watch
Ticker
AVLN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452463191
Phone
(206) 707-0340
Business address
105 W FIRST ST., BOSTON, MA, 02127
Former names
Genoa Pharmaceuticals, Inc.
Filings Insiders Search text
All 66 Financials 10 Executive Compensation 7 Insider Trading 32 Beneficial Ownership Interest 7 Business Combinations 7 Public Offerings 4 Others 13
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-14
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-11
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-08-06
  5. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-05-08
  6. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-05-08
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-05-07
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-05-05

Page 1 of 1 · 7 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…